WCG IPO Presentation Deck

8 Our Large, Growing and Diversified Client Base Client Composition 5,000+ Pharma & CRO Clients 160,000+ Global Principal Investigators Ecosystem Engagement 290,000 Readers of WCG Publications 3,300+ Academic Medical Centers & Institutions 2.5mm Patients Engaged 80,000+ Annual Conference & Webinar Attendees Abbott Biogen Pfizer Shire Clinipace GIOVIA PPD PSI Large Biopharma 50 of 50 Top Pharma by Revenue abbvie BIOMARIN Eisal Otsuka Genentech Lilly Lilly MERCK REGENERON Allergan AMGEN AstraZeneca TEUN COVANCE MEOPACE Rho GILEAD CROS 8 of 8 Top CROS by Revenue -200 Small/Mid CROS ICON 6 NOVARTIS Roche Blue Chip Client Base PAREXEL premier Syneos esk SANOFI VERTEX integrim Pharm-Olam *ProTrials 00 Amicus CENTREXION SAREPTA Intercept IONIS PACIRA O EMORY HEALTHCARE PARTNERS Small & Mid-Cap Biopharma 4,000+ Akebia Tufts agios relypsa Spark Top 5 Clients Representing <25% of Total Revenue Conatusy Beifiene HEALTH SYSTEM Ucla Karyopharm ALECTOR #TESARO Institutions & Investigators 3,300+ Institutions & AMCS Epizyme Raplimune Revance TONIX NYU Langone RUTGERS U Medical Deter wcg DNL 2 Alnylam Celldex Incyte NEKTAR SAGE Trevena UFHealth

View entire presentation